Overview
Yasuo Ihara practices practicing medicine in Tokyo, Japan.
His clinical expertise encompasses Alzheimer's Disease, Dementia, Cerebral Amyloid Angiopathy, and Primary Amyloidosis.
He is actively involved in clinical research, co-authoring 45 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yasuo Ihara
Is Yasuo Ihara a top-rated expert for Alzheimer's Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Yasuo Ihara is classified as an Experienced expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yasuo Ihara participate in research or clinical trials?
Yes. Yasuo Ihara has published 45 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Yasuo Ihara's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseMr. Ihara isExperienced. Learn about Alzheimer's Disease.
- Cerebral Amyloid AngiopathyMr. Ihara isExperienced. Learn about Cerebral Amyloid Angiopathy.
- DementiaMr. Ihara isExperienced. Learn about Dementia.
- Primary AmyloidosisMr. Ihara isExperienced. Learn about Primary Amyloidosis.